MedPath

RIZATRIPTAN BENZOATE

These highlights do not include all the information needed to use RIZATRIPTAN BENZOATE ORALLY DISINTEGRATING TABLETS, USP safely and effectively. See full prescribing information for RIZATRIPTAN BENZOATE ORALLY DISINTEGRATING TABLETS, USP. RIZATRIPTAN BENZOATE orally disintegrating tablets, USP Initial U.S. Approval: 1998

Approved
Approval ID

9c70370d-72ac-e062-e25c-97d57e6397ab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 2, 2021

Manufacturers
FDA

Panacea Biotec Limited

DUNS: 650090566

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

rizatriptan benzoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43817-135
Application NumberANDA204722
Product Classification
M
Marketing Category
C73584
G
Generic Name
rizatriptan benzoate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 2, 2021
FDA Product Classification

INGREDIENTS (13)

MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
RIZATRIPTAN BENZOATEActive
Quantity: 10 mg in 1 1
Code: WR978S7QHH
Classification: ACTIM
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT

rizatriptan benzoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43817-133
Application NumberANDA204722
Product Classification
M
Marketing Category
C73584
G
Generic Name
rizatriptan benzoate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 2, 2021
FDA Product Classification

INGREDIENTS (13)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
RIZATRIPTAN BENZOATEActive
Quantity: 5 mg in 1 1
Code: WR978S7QHH
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.